Continue to meet or exceed healthcare partners’ expectations by providing on-time test results approximately 92 percent of the time.
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...